Since 7000 BCE, humans have fermented sugars into ethanol, and since work by Louis Pasteur in the 1850s, we have known that microorganisms are responsible for this miraculous feat of chemical synthesis [1] . Since then, the ability of biological organisms to cheaply and selectively transform chemicals into useful products has been exploited on a global scale from agriculture to biotechnological synthesis of pharmaceutical compounds. Recently, photosynthetic conversion of CO 2 into organic compounds using solar energy by algae, cyanobacteria and plants has garnered much attention as a possible solution to mitigate climate change resulting from rising levels of greenhouse gases. However, despite the remarkable capabilities of biology to fix CO 2 into compounds that might be used as food, fuel or commodity chemicals, their efficiencies typically remain too low (~0.2%-1.6%) due to their limited light absorption [2] .
Recently, efforts have been directed to augmenting bacterial CO 2 fixation with inorganic, semiconductor light harvesters in the form of photoelectrochemical devices [3] [4] [5] . Such devices often employ a biocompatible semiconductor electrode and metal co-catalysts that split water into hydrogen and oxygen with a photogenerated electron-hole pair. The hydrogen is then fed to autotrophic bacteria that combine it with CO 2 to produce a number of compounds including organic acids, alcohols and methane. While such photovoltaic and photoelectrochemical devices can achieve significantly higher solar-energy conversion efficiencies (10%-20%), their widespread implementation is still plagued by manufacturing and material costs associated with the microfabrication techniques required to produce such devices.
Again, biological systems offer a potential solution to the high cost associated with semiconductor synthesis. Bacteria, yeast, and viruses have all been shown to produce a variety of metal, and metal chalcogenide semiconductor nanoparticles, affording a low cost route to light absorbing 
